Attorneys at Bass, Berry & Sims assisted AmSurg Corp. with its acquisition of Sheridan Healthcare Inc. from private equity firm Hellman & Friedman LLC for about $2.35 billion in cash and stock. Our team worked on completing healthcare regulatory, corporate, real estate, benefits and labor due diligence, negotiating all related deal documents, and handling the related SEC filings required to be made by AmSurg.
To read the full description of our involvement in the deal, click here.
The links below provide access to some of the media coverage surrounding the acquisition:
“AmSurg Pays $2.35B for PE-Backed Sheridan Healthcare” – Law360
“Simpson, Bass Berry Lead as AmSurg Snags Sheridan” – The American Lawyer (subscription required)
“‘Transformative’ Deal to Take AmSurg into Physician Services” – Nashville Post
Bass Berry, Simpson on AmSurg Agreement to Buy Sheridan” – Bloomberg